Eleonora Bianchi

Papers

Total Citations

H-Index

About

Eleonora Bianchi is a leading researcher at the intersection of pharmaceutical engineering and regulatory science, with a primary focus on the aseptic manufacturing of advanced nanomedicines. Her work addresses a critical bottleneck in the field: translating complex nanomedicine-based products from the lab bench to commercial, continuous production while satisfying stringent regulatory requirements. Bianchi’s most cited paper, “Robotics and Aseptic Processing in View of Regulatory Requirements” (2023), has already garnered 6 citations, highlighting its timely relevance. In this work, she analyzes how the COVID-19 pandemic accelerated the market entry of several nanomedicinal products, exposing key challenges in scalability and batch reproducibility. Bianchi’s major contribution lies in proposing robotic automation as a solution to maintain aseptic integrity during continuous manufacturing—a paradigm shift from traditional batch processing. Her research is pivotal for ensuring that next-generation therapies, such as lipid nanoparticle-based vaccines and RNA therapeutics, can be produced reliably and at scale. By bridging engineering innovation with regulatory foresight, Bianchi is helping to shape the future of pharmaceutical production, making her a vital voice for students and researchers navigating the complexities of modern drug manufacturing.